Class IIReported 2025-07-09

Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61

Recalled by The Harvard Drug Group LLC

Reason for Recall

Defective container; blister packaging inadequately sealed.

Recall Number

D-0507-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-06-19

Reported

2025-07-09

Distribution

Nationwide

Code Info

Lot# M05205, Exp Date 10/2026

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.